Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compromised arterial function in human type 2 diabetic patients.

Elena B Okon1, Ada W Y Chung, Pooja Rauniyar

  • 1James Hogg iCAPTURE Center, St. Paul's Hospital, Room 166, 1081 Burrard St., Vancouver, BC, Canada V6Z 1Y6. eokon@mrl.ubc.ca

Diabetes
|July 28, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artesunate Induces G0/G1 Phase Arrest in Tumor Cells and Associates With Cyclin-Dependent Kinase 4 (CDK4).

Cancer medicine·2026
Same author

Bioinformatics strategies and biomarker refinement using high-throughput transcriptome data in transplantation.

Frontiers in bioinformatics·2026
Same author

Genetic factors contributing to viral myocarditis.

Microbiology and molecular biology reviews : MMBR·2026
Same author

The Gut-Liver Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease: From Mechanistic Insights to Precision Therapeutics.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Omics BioAnalytics: an RShiny application for multimodal biomarker panel discovery and assessment.

Bioinformatics advances·2026
Same author

STD-Net: a spatio-temporal decoupling network for multiphasic liver lesion segmentation and characterization.

NPJ digital medicine·2025

Diabetes impairs insulin signaling and reduces nitric oxide (NO) production in blood vessels, leading to hypertension and atherosclerosis. This study investigated these mechanisms in diabetic arteries, revealing impaired Akt phosphorylation and NO synthase function.

Area of Science:

  • Vascular Biology
  • Endocrinology
  • Cardiovascular Research

Background:

  • Diabetes mellitus is linked to vascular complications like hypertension and atherosclerosis.
  • These conditions arise from signaling pathway disruptions in vascular tissue, causing vasomotor dysfunction.
  • Endothelial dysfunction and altered nitric oxide (NO) bioavailability are key factors.

Purpose of the Study:

  • To investigate the mechanisms of vasomotor dysfunction in human diabetic arteries.
  • To examine Akt phosphorylation, endothelial NO synthase (eNOS), and inducible NO synthase (iNOS) expression.
  • To elucidate the roles of NO-dependent and NO-independent pathways in diabetic vascular impairment.

Main Methods:

  • Analysis of Akt phosphorylation (Thr308 and Ser473) in diabetic and non-diabetic human internal mammary arteries.

Related Experiment Videos

  • Measurement of endothelial NO synthase (eNOS) and inducible NO synthase (iNOS) expression and activity.
  • Assessment of vascular response to NO donors and inhibitors in vitro.

    • Main Results:

    • Diabetic arteries showed reduced phospho-Akt (Thr308) levels, indicating impaired insulin signaling.
    • Vasoconstriction was augmented in diabetic arteries, associated with decreased eNOS expression and activity.
    • Reduced sensitivity to NO donors and preserved vasoconstriction with NOS inhibition suggested NO breakdown and NO-independent mechanisms.

    Conclusions:

    • Diabetes downregulates the Akt signaling pathway in human arteries.
    • Impaired NO availability and NO-independent pathways contribute to diabetic vasomotor dysfunction.
    • These vascular changes underlie hypertension and accelerated atherosclerosis in diabetes.